Journal profile · RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Molecular Imaging and Radionuclide Therapy

ISSN 2146-1414 · eISSN 2147-1959 · Galenos Yayinevi

Molecular Imaging and Radionuclide Therapy: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; 60 articles in 2025; indexed in ESCI and Scopus.

Impact factor—No published value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
CiteScore quartileQ3Radiology, Nuclear Medicine and Imaging · rank 248/361 · 31st percentile
Review time—No reports yet
APC—No source gives fee information
Acceptance—No reports yet
Articles per year602025 · OpenAlex count

Scope

Aims, scope and focus

Molecular Imaging and Radionuclide Therapy is published by Galenos Yayinevi and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications and Thyroid Cancer Diagnosis and Treatment, together about 50.6% of its articles. Its main subfields are Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Medical Imaging Techniques and ApplicationsMedicine30.7%
  2. Radiopharmaceutical Chemistry and ApplicationsMedicine12.8%
  3. Thyroid Cancer Diagnosis and TreatmentMedicine7.1%
  4. Thyroid and Parathyroid SurgeryMedicine4.5%
  5. Lung Cancer Diagnosis and TreatmentMedicine4.2%
  6. Neuroendocrine Tumor Research AdvancesMedicine4.2%
  7. Cardiac Imaging and DiagnosticsMedicine3.6%
  8. Thyroid Disorders and TreatmentsMedicine3.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRadiology, Nuclear Medicine & Medical ImagingZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRadiology, Nuclear Medicine & Medical ImagingZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

SubjectQuartileRankPercentile
Radiology, Nuclear Medicine and ImagingQ3248/36131st

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ESCIScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
1.5LetPub ·
SJR 2026-06
0.27LetPub ·
SNIP 2026-06
0.42LetPub ·
h-index
26OpenAlex ·
i10-index
102OpenAlex ·
2-year mean citedness
0.77OpenAlex ·
Self-citation rate
11.1%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
49LetPub ·

Articles by year OpenAlex count · 577 in total · the current year is incomplete

YearArticlesOpen accessCitations
20263737273
20256060382
20245252373
20235353335
20224949387
20213636308

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Fees & open access

APC and open-access policy

Fully open accessOpenAlex

Every article is open access; authors usually pay an article processing charge (APC).

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Galenos Yayinevi
ISSN
2146-1414
Electronic ISSN
2147-1959
Official links

FAQ

Frequently asked questions about Molecular Imaging and Radionuclide Therapy

What CAS zone is Molecular Imaging and Radionuclide Therapy in?

In the 2025 upgraded edition of the CAS Journal Ranking, Molecular Imaging and Radionuclide Therapy is in Zone 4 of Medicine, and in Zone 4 of the minor category Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

Which databases index Molecular Imaging and Radionuclide Therapy?

According to LetPub and DOAJ records, Molecular Imaging and Radionuclide Therapy is indexed in ESCI and Scopus.

Is Molecular Imaging and Radionuclide Therapy open access, and what is the APC?

Molecular Imaging and Radionuclide Therapy is a fully open-access journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .